title: High-dose chemotherapy and autologous CD34-positive blood stem cell transplantation for multiple myeloma in an HIV carrier.
abstract: The epidemiology and clinical outcome of multiple myeloma in human immunodeficiency virus (HIV)-positive patients is poorly documented. There are uncertainties concerning the optimal management of this rare disorder. We report on the use of myeloablative chemotherapy with autologous stem cell transplantation in an HIV-positive patient with multiple myeloma.
authors.affiliation: Clinique d'Hématologie, ULB-Hôpital Erasme, Free University of Brussels, Brussels, Belgium.
authors.forename: A
authors.initials: A
authors.lastname: Kentos
authors.forename: M
authors.initials: M
authors.lastname: Vekemans
authors.forename: J P
authors.initials: JP
authors.lastname: Van Vooren
authors.forename: M
authors.initials: M
authors.lastname: Lambermont
authors.forename: C
authors.initials: C
authors.lastname: Liesnard
authors.forename: W
authors.initials: W
authors.lastname: Feremans
authors.forename: C M
authors.initials: CM
authors.lastname: Farber
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000150:complications* / Q000628:therapy; D000328:Adult; D018952:Antigens, CD34 / Q000097:blood*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D017809:Fatal Outcome; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D009101:Multiple Myeloma / Q000628:therapy* / Q000821:virology*; D014182:Transplantation, Autologous
chemical_list: D018952:Antigens, CD34